nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1B1—melanoma	0.331	0.769	CbGaD
Propofol—ALB—melanoma	0.0995	0.231	CbGaD
Propofol—CYP1B1—Docetaxel—melanoma	0.0562	0.146	CbGbCtD
Propofol—CYP1A1—Dacarbazine—melanoma	0.0551	0.143	CbGbCtD
Propofol—ALB—Vemurafenib—melanoma	0.0536	0.14	CbGbCtD
Propofol—CYP2E1—Dacarbazine—melanoma	0.0425	0.111	CbGbCtD
Propofol—CYP1A2—Carmustine—melanoma	0.0406	0.106	CbGbCtD
Propofol—CYP1A2—Vemurafenib—melanoma	0.0321	0.0835	CbGbCtD
Propofol—CYP3A4—Temozolomide—melanoma	0.0307	0.0798	CbGbCtD
Propofol—CYP2D6—Vemurafenib—melanoma	0.0264	0.0688	CbGbCtD
Propofol—CYP1A2—Dacarbazine—melanoma	0.0246	0.064	CbGbCtD
Propofol—CYP3A4—Vemurafenib—melanoma	0.0168	0.0437	CbGbCtD
Propofol—CYP3A4—Docetaxel—melanoma	0.00577	0.015	CbGbCtD
Propofol—Intracranial pressure increased—Carmustine—melanoma	0.00153	0.0203	CcSEcCtD
Propofol—Hypomagnesaemia—Bleomycin—melanoma	0.00115	0.0153	CcSEcCtD
Propofol—Atrial fibrillation—Vemurafenib—melanoma	0.000924	0.0123	CcSEcCtD
Propofol—Thrombosis—Carmustine—melanoma	0.000902	0.012	CcSEcCtD
Propofol—Pain in extremity—Vemurafenib—melanoma	0.000876	0.0116	CcSEcCtD
Propofol—Coagulopathy—Dactinomycin—melanoma	0.000876	0.0116	CcSEcCtD
Propofol—Extravasation—Bleomycin—melanoma	0.000838	0.0111	CcSEcCtD
Propofol—Coagulopathy—Temozolomide—melanoma	0.000792	0.0105	CcSEcCtD
Propofol—Injection site pain—Carmustine—melanoma	0.000782	0.0104	CcSEcCtD
Propofol—Extravasation—Dactinomycin—melanoma	0.000782	0.0104	CcSEcCtD
Propofol—Extravasation—Carmustine—melanoma	0.000731	0.00971	CcSEcCtD
Propofol—Wheezing—Bleomycin—melanoma	0.00071	0.00943	CcSEcCtD
Propofol—Thinking abnormal—Carmustine—melanoma	0.000697	0.00925	CcSEcCtD
Propofol—Leukocytosis—Carmustine—melanoma	0.000679	0.00901	CcSEcCtD
Propofol—Neuropathy peripheral—Vemurafenib—melanoma	0.000662	0.00878	CcSEcCtD
Propofol—Fospropofol—ALB—melanoma	0.000659	1	CrCbGaD
Propofol—Respiratory failure—Temozolomide—melanoma	0.000628	0.00834	CcSEcCtD
Propofol—Supraventricular tachycardia—Docetaxel—melanoma	0.000626	0.00831	CcSEcCtD
Propofol—Phlebitis—Bleomycin—melanoma	0.000616	0.00818	CcSEcCtD
Propofol—Redness—Docetaxel—melanoma	0.000608	0.00807	CcSEcCtD
Propofol—Neuropathy—Carmustine—melanoma	0.000599	0.00795	CcSEcCtD
Propofol—Sepsis—Dactinomycin—melanoma	0.000592	0.00786	CcSEcCtD
Propofol—Ileus—Docetaxel—melanoma	0.000579	0.00769	CcSEcCtD
Propofol—Neuropathy—Temozolomide—melanoma	0.000579	0.00769	CcSEcCtD
Propofol—Phlebitis—Dactinomycin—melanoma	0.000575	0.00763	CcSEcCtD
Propofol—Abnormal vision—Carmustine—melanoma	0.000557	0.00739	CcSEcCtD
Propofol—Mental disability—Carmustine—melanoma	0.000554	0.00735	CcSEcCtD
Propofol—Sepsis—Carmustine—melanoma	0.000554	0.00735	CcSEcCtD
Propofol—Chills—Vemurafenib—melanoma	0.000544	0.00722	CcSEcCtD
Propofol—Abnormal vision—Temozolomide—melanoma	0.000538	0.00714	CcSEcCtD
Propofol—Phlebitis—Carmustine—melanoma	0.000538	0.00714	CcSEcCtD
Propofol—Mental disability—Temozolomide—melanoma	0.000535	0.0071	CcSEcCtD
Propofol—Erythema—Vemurafenib—melanoma	0.000528	0.007	CcSEcCtD
Propofol—Ear pain—Temozolomide—melanoma	0.000525	0.00697	CcSEcCtD
Propofol—Dysgeusia—Vemurafenib—melanoma	0.000517	0.00686	CcSEcCtD
Propofol—Eye pain—Carmustine—melanoma	0.000513	0.00681	CcSEcCtD
Propofol—Myocardial ischaemia—Docetaxel—melanoma	0.00051	0.00677	CcSEcCtD
Propofol—Eye pain—Temozolomide—melanoma	0.000496	0.00658	CcSEcCtD
Propofol—Extravasation—Docetaxel—melanoma	0.00047	0.00624	CcSEcCtD
Propofol—Diplopia—Carmustine—melanoma	0.000463	0.00615	CcSEcCtD
Propofol—Cough—Vemurafenib—melanoma	0.00046	0.00611	CcSEcCtD
Propofol—Bronchospasm—Bleomycin—melanoma	0.000451	0.00599	CcSEcCtD
Propofol—Myalgia—Vemurafenib—melanoma	0.000449	0.00596	CcSEcCtD
Propofol—Diplopia—Temozolomide—melanoma	0.000448	0.00594	CcSEcCtD
Propofol—Oliguria—Docetaxel—melanoma	0.000445	0.00591	CcSEcCtD
Propofol—Affect lability—Temozolomide—melanoma	0.000441	0.00585	CcSEcCtD
Propofol—Anaphylactic shock—Vemurafenib—melanoma	0.000431	0.00572	CcSEcCtD
Propofol—Mood swings—Temozolomide—melanoma	0.000424	0.00563	CcSEcCtD
Propofol—Respiratory failure—Docetaxel—melanoma	0.000418	0.00554	CcSEcCtD
Propofol—Dehydration—Temozolomide—melanoma	0.000416	0.00553	CcSEcCtD
Propofol—Acute coronary syndrome—Bleomycin—melanoma	0.000403	0.00535	CcSEcCtD
Propofol—Hypotension—Vemurafenib—melanoma	0.000402	0.00534	CcSEcCtD
Propofol—Myocardial infarction—Bleomycin—melanoma	0.000401	0.00532	CcSEcCtD
Propofol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000392	0.00521	CcSEcCtD
Propofol—Neuropathy—Docetaxel—melanoma	0.000385	0.00511	CcSEcCtD
Propofol—Sweating increased—Temozolomide—melanoma	0.000377	0.005	CcSEcCtD
Propofol—Fatigue—Vemurafenib—melanoma	0.000371	0.00493	CcSEcCtD
Propofol—Haemoglobin—Bleomycin—melanoma	0.000369	0.0049	CcSEcCtD
Propofol—Haemorrhage—Bleomycin—melanoma	0.000367	0.00487	CcSEcCtD
Propofol—Pulmonary oedema—Docetaxel—melanoma	0.000365	0.00485	CcSEcCtD
Propofol—Hyperglycaemia—Carmustine—melanoma	0.000361	0.00479	CcSEcCtD
Propofol—Depression—Carmustine—melanoma	0.000356	0.00473	CcSEcCtD
Propofol—Sepsis—Docetaxel—melanoma	0.000356	0.00472	CcSEcCtD
Propofol—Renal failure—Carmustine—melanoma	0.000351	0.00466	CcSEcCtD
Propofol—Neuropathy peripheral—Carmustine—melanoma	0.00035	0.00465	CcSEcCtD
Propofol—Hyperglycaemia—Temozolomide—melanoma	0.000349	0.00463	CcSEcCtD
Propofol—Phlebitis—Docetaxel—melanoma	0.000346	0.00459	CcSEcCtD
Propofol—Depression—Temozolomide—melanoma	0.000344	0.00457	CcSEcCtD
Propofol—Flushing—Bleomycin—melanoma	0.000341	0.00452	CcSEcCtD
Propofol—Body temperature increased—Vemurafenib—melanoma	0.00034	0.00452	CcSEcCtD
Propofol—Pharyngitis—Dactinomycin—melanoma	0.00034	0.00451	CcSEcCtD
Propofol—Neuropathy peripheral—Temozolomide—melanoma	0.000338	0.00449	CcSEcCtD
Propofol—Chills—Bleomycin—melanoma	0.000329	0.00437	CcSEcCtD
Propofol—Haemoglobin—Carmustine—melanoma	0.000322	0.00428	CcSEcCtD
Propofol—Haemorrhage—Carmustine—melanoma	0.00032	0.00425	CcSEcCtD
Propofol—Erythema—Bleomycin—melanoma	0.00032	0.00424	CcSEcCtD
Propofol—Hallucination—Carmustine—melanoma	0.000319	0.00423	CcSEcCtD
Propofol—Flushing—Dactinomycin—melanoma	0.000318	0.00422	CcSEcCtD
Propofol—Atrial fibrillation—Docetaxel—melanoma	0.000314	0.00417	CcSEcCtD
Propofol—Haemoglobin—Temozolomide—melanoma	0.000311	0.00413	CcSEcCtD
Propofol—Haemorrhage—Temozolomide—melanoma	0.00031	0.00411	CcSEcCtD
Propofol—Asthenia—Vemurafenib—melanoma	0.000309	0.0041	CcSEcCtD
Propofol—Visual impairment—Carmustine—melanoma	0.000309	0.0041	CcSEcCtD
Propofol—Hallucination—Temozolomide—melanoma	0.000308	0.00409	CcSEcCtD
Propofol—Pharyngitis—Temozolomide—melanoma	0.000307	0.00408	CcSEcCtD
Propofol—Chills—Dactinomycin—melanoma	0.000307	0.00408	CcSEcCtD
Propofol—Cardiac failure—Docetaxel—melanoma	0.000305	0.00405	CcSEcCtD
Propofol—Pruritus—Vemurafenib—melanoma	0.000305	0.00404	CcSEcCtD
Propofol—Visual impairment—Temozolomide—melanoma	0.000298	0.00396	CcSEcCtD
Propofol—Erythema—Dactinomycin—melanoma	0.000298	0.00396	CcSEcCtD
Propofol—Pain in extremity—Docetaxel—melanoma	0.000298	0.00395	CcSEcCtD
Propofol—Flushing—Carmustine—melanoma	0.000297	0.00395	CcSEcCtD
Propofol—Diarrhoea—Vemurafenib—melanoma	0.000295	0.00391	CcSEcCtD
Propofol—Tinnitus—Temozolomide—melanoma	0.000289	0.00383	CcSEcCtD
Propofol—Flushing—Temozolomide—melanoma	0.000287	0.00382	CcSEcCtD
Propofol—Arrhythmia—Carmustine—melanoma	0.000286	0.0038	CcSEcCtD
Propofol—Dizziness—Vemurafenib—melanoma	0.000285	0.00378	CcSEcCtD
Propofol—Erythema—Carmustine—melanoma	0.000279	0.0037	CcSEcCtD
Propofol—Cough—Bleomycin—melanoma	0.000279	0.0037	CcSEcCtD
Propofol—Chills—Temozolomide—melanoma	0.000278	0.00369	CcSEcCtD
Propofol—Dehydration—Docetaxel—melanoma	0.000277	0.00368	CcSEcCtD
Propofol—Vomiting—Vemurafenib—melanoma	0.000274	0.00363	CcSEcCtD
Propofol—Myalgia—Bleomycin—melanoma	0.000272	0.00361	CcSEcCtD
Propofol—Chest pain—Bleomycin—melanoma	0.000272	0.00361	CcSEcCtD
Propofol—Rash—Vemurafenib—melanoma	0.000271	0.0036	CcSEcCtD
Propofol—Dermatitis—Vemurafenib—melanoma	0.000271	0.0036	CcSEcCtD
Propofol—Headache—Vemurafenib—melanoma	0.00027	0.00358	CcSEcCtD
Propofol—Erythema—Temozolomide—melanoma	0.00027	0.00358	CcSEcCtD
Propofol—Cramp muscle—Docetaxel—melanoma	0.000268	0.00356	CcSEcCtD
Propofol—Dysgeusia—Temozolomide—melanoma	0.000264	0.0035	CcSEcCtD
Propofol—Confusional state—Bleomycin—melanoma	0.000263	0.00349	CcSEcCtD
Propofol—Tremor—Carmustine—melanoma	0.000261	0.00347	CcSEcCtD
Propofol—Anaphylactic shock—Bleomycin—melanoma	0.000261	0.00346	CcSEcCtD
Propofol—Oedema—Bleomycin—melanoma	0.000261	0.00346	CcSEcCtD
Propofol—Agitation—Carmustine—melanoma	0.000256	0.0034	CcSEcCtD
Propofol—Nausea—Vemurafenib—melanoma	0.000256	0.00339	CcSEcCtD
Propofol—Myalgia—Dactinomycin—melanoma	0.000254	0.00337	CcSEcCtD
Propofol—Bronchospasm—Docetaxel—melanoma	0.000253	0.00336	CcSEcCtD
Propofol—Tremor—Temozolomide—melanoma	0.000253	0.00335	CcSEcCtD
Propofol—Agitation—Temozolomide—melanoma	0.000248	0.00329	CcSEcCtD
Propofol—Angioedema—Temozolomide—melanoma	0.000246	0.00327	CcSEcCtD
Propofol—Hypotension—Bleomycin—melanoma	0.000244	0.00324	CcSEcCtD
Propofol—Oedema—Dactinomycin—melanoma	0.000243	0.00323	CcSEcCtD
Propofol—Convulsion—Carmustine—melanoma	0.000242	0.00321	CcSEcCtD
Propofol—Hypertension—Carmustine—melanoma	0.000241	0.0032	CcSEcCtD
Propofol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000238	0.00315	CcSEcCtD
Propofol—Chest pain—Carmustine—melanoma	0.000238	0.00315	CcSEcCtD
Propofol—Myalgia—Carmustine—melanoma	0.000238	0.00315	CcSEcCtD
Propofol—Anxiety—Carmustine—melanoma	0.000237	0.00314	CcSEcCtD
Propofol—Cough—Temozolomide—melanoma	0.000235	0.00312	CcSEcCtD
Propofol—Paraesthesia—Bleomycin—melanoma	0.000234	0.00311	CcSEcCtD
Propofol—Convulsion—Temozolomide—melanoma	0.000234	0.0031	CcSEcCtD
Propofol—Hypertension—Temozolomide—melanoma	0.000233	0.00309	CcSEcCtD
Propofol—Dyspnoea—Bleomycin—melanoma	0.000233	0.00309	CcSEcCtD
Propofol—Confusional state—Carmustine—melanoma	0.00023	0.00305	CcSEcCtD
Propofol—Myalgia—Temozolomide—melanoma	0.00023	0.00305	CcSEcCtD
Propofol—Anxiety—Temozolomide—melanoma	0.000229	0.00304	CcSEcCtD
Propofol—Oedema—Carmustine—melanoma	0.000228	0.00302	CcSEcCtD
Propofol—Acute coronary syndrome—Docetaxel—melanoma	0.000226	0.003	CcSEcCtD
Propofol—Renal failure—Docetaxel—melanoma	0.000226	0.00299	CcSEcCtD
Propofol—Myocardial infarction—Docetaxel—melanoma	0.000225	0.00299	CcSEcCtD
Propofol—Neuropathy peripheral—Docetaxel—melanoma	0.000225	0.00299	CcSEcCtD
Propofol—Dry mouth—Temozolomide—melanoma	0.000224	0.00298	CcSEcCtD
Propofol—Pain—Bleomycin—melanoma	0.000223	0.00296	CcSEcCtD
Propofol—Tachycardia—Carmustine—melanoma	0.000222	0.00295	CcSEcCtD
Propofol—Confusional state—Temozolomide—melanoma	0.000222	0.00295	CcSEcCtD
Propofol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000222	0.00294	CcSEcCtD
Propofol—Anaphylactic shock—Temozolomide—melanoma	0.00022	0.00292	CcSEcCtD
Propofol—Oedema—Temozolomide—melanoma	0.00022	0.00292	CcSEcCtD
Propofol—Feeling abnormal—Bleomycin—melanoma	0.000215	0.00285	CcSEcCtD
Propofol—Hypotension—Carmustine—melanoma	0.000213	0.00282	CcSEcCtD
Propofol—Hyperhidrosis—Temozolomide—melanoma	0.000213	0.00282	CcSEcCtD
Propofol—Fatigue—Dactinomycin—melanoma	0.00021	0.00278	CcSEcCtD
Propofol—Pain—Dactinomycin—melanoma	0.000208	0.00276	CcSEcCtD
Propofol—Musculoskeletal discomfort—Carmustine—melanoma	0.000207	0.00275	CcSEcCtD
Propofol—Urticaria—Bleomycin—melanoma	0.000207	0.00275	CcSEcCtD
Propofol—Haemoglobin—Docetaxel—melanoma	0.000207	0.00275	CcSEcCtD
Propofol—Body temperature increased—Bleomycin—melanoma	0.000206	0.00274	CcSEcCtD
Propofol—Haemorrhage—Docetaxel—melanoma	0.000206	0.00273	CcSEcCtD
Propofol—Insomnia—Carmustine—melanoma	0.000206	0.00273	CcSEcCtD
Propofol—Paraesthesia—Carmustine—melanoma	0.000204	0.00271	CcSEcCtD
Propofol—Pharyngitis—Docetaxel—melanoma	0.000204	0.00271	CcSEcCtD
Propofol—Dyspnoea—Carmustine—melanoma	0.000203	0.00269	CcSEcCtD
Propofol—Somnolence—Carmustine—melanoma	0.000202	0.00269	CcSEcCtD
Propofol—Feeling abnormal—Dactinomycin—melanoma	0.0002	0.00266	CcSEcCtD
Propofol—Musculoskeletal discomfort—Temozolomide—melanoma	0.0002	0.00266	CcSEcCtD
Propofol—Insomnia—Temozolomide—melanoma	0.000199	0.00264	CcSEcCtD
Propofol—Visual impairment—Docetaxel—melanoma	0.000198	0.00263	CcSEcCtD
Propofol—Paraesthesia—Temozolomide—melanoma	0.000198	0.00262	CcSEcCtD
Propofol—Dyspnoea—Temozolomide—melanoma	0.000196	0.0026	CcSEcCtD
Propofol—Somnolence—Temozolomide—melanoma	0.000196	0.0026	CcSEcCtD
Propofol—Pain—Carmustine—melanoma	0.000195	0.00258	CcSEcCtD
Propofol—Body temperature increased—Dactinomycin—melanoma	0.000192	0.00255	CcSEcCtD
Propofol—Abdominal pain—Dactinomycin—melanoma	0.000192	0.00255	CcSEcCtD
Propofol—Flushing—Docetaxel—melanoma	0.000191	0.00254	CcSEcCtD
Propofol—Fatigue—Temozolomide—melanoma	0.00019	0.00252	CcSEcCtD
Propofol—Pain—Temozolomide—melanoma	0.000188	0.0025	CcSEcCtD
Propofol—Feeling abnormal—Carmustine—melanoma	0.000188	0.00249	CcSEcCtD
Propofol—Asthenia—Bleomycin—melanoma	0.000187	0.00248	CcSEcCtD
Propofol—Chills—Docetaxel—melanoma	0.000185	0.00245	CcSEcCtD
Propofol—Pruritus—Bleomycin—melanoma	0.000185	0.00245	CcSEcCtD
Propofol—Arrhythmia—Docetaxel—melanoma	0.000184	0.00244	CcSEcCtD
Propofol—Feeling abnormal—Temozolomide—melanoma	0.000181	0.00241	CcSEcCtD
Propofol—Abdominal pain—Carmustine—melanoma	0.00018	0.00239	CcSEcCtD
Propofol—Body temperature increased—Carmustine—melanoma	0.00018	0.00239	CcSEcCtD
Propofol—Erythema—Docetaxel—melanoma	0.000179	0.00238	CcSEcCtD
Propofol—Dysgeusia—Docetaxel—melanoma	0.000176	0.00233	CcSEcCtD
Propofol—Urticaria—Temozolomide—melanoma	0.000175	0.00232	CcSEcCtD
Propofol—Asthenia—Dactinomycin—melanoma	0.000175	0.00232	CcSEcCtD
Propofol—Body temperature increased—Temozolomide—melanoma	0.000174	0.00231	CcSEcCtD
Propofol—Abdominal pain—Temozolomide—melanoma	0.000174	0.00231	CcSEcCtD
Propofol—Muscle spasms—Docetaxel—melanoma	0.000172	0.00229	CcSEcCtD
Propofol—Diarrhoea—Dactinomycin—melanoma	0.000166	0.00221	CcSEcCtD
Propofol—Vomiting—Bleomycin—melanoma	0.000166	0.0022	CcSEcCtD
Propofol—Rash—Bleomycin—melanoma	0.000164	0.00218	CcSEcCtD
Propofol—Dermatitis—Bleomycin—melanoma	0.000164	0.00218	CcSEcCtD
Propofol—Asthenia—Carmustine—melanoma	0.000163	0.00217	CcSEcCtD
Propofol—Syncope—Docetaxel—melanoma	0.000161	0.00213	CcSEcCtD
Propofol—Asthenia—Temozolomide—melanoma	0.000158	0.0021	CcSEcCtD
Propofol—Loss of consciousness—Docetaxel—melanoma	0.000158	0.00209	CcSEcCtD
Propofol—Cough—Docetaxel—melanoma	0.000156	0.00208	CcSEcCtD
Propofol—Diarrhoea—Carmustine—melanoma	0.000156	0.00207	CcSEcCtD
Propofol—Pruritus—Temozolomide—melanoma	0.000156	0.00207	CcSEcCtD
Propofol—Convulsion—Docetaxel—melanoma	0.000155	0.00206	CcSEcCtD
Propofol—Nausea—Bleomycin—melanoma	0.000155	0.00206	CcSEcCtD
Propofol—Hypertension—Docetaxel—melanoma	0.000155	0.00205	CcSEcCtD
Propofol—Vomiting—Dactinomycin—melanoma	0.000155	0.00205	CcSEcCtD
Propofol—Rash—Dactinomycin—melanoma	0.000153	0.00204	CcSEcCtD
Propofol—Myalgia—Docetaxel—melanoma	0.000153	0.00203	CcSEcCtD
Propofol—Chest pain—Docetaxel—melanoma	0.000153	0.00203	CcSEcCtD
Propofol—Dizziness—Carmustine—melanoma	0.000151	0.002	CcSEcCtD
Propofol—Diarrhoea—Temozolomide—melanoma	0.000151	0.002	CcSEcCtD
Propofol—Dry mouth—Docetaxel—melanoma	0.000149	0.00198	CcSEcCtD
Propofol—Confusional state—Docetaxel—melanoma	0.000148	0.00196	CcSEcCtD
Propofol—Anaphylactic shock—Docetaxel—melanoma	0.000146	0.00194	CcSEcCtD
Propofol—Oedema—Docetaxel—melanoma	0.000146	0.00194	CcSEcCtD
Propofol—Dizziness—Temozolomide—melanoma	0.000146	0.00193	CcSEcCtD
Propofol—Vomiting—Carmustine—melanoma	0.000145	0.00192	CcSEcCtD
Propofol—Nausea—Dactinomycin—melanoma	0.000145	0.00192	CcSEcCtD
Propofol—Shock—Docetaxel—melanoma	0.000144	0.00191	CcSEcCtD
Propofol—Rash—Carmustine—melanoma	0.000144	0.00191	CcSEcCtD
Propofol—Dermatitis—Carmustine—melanoma	0.000143	0.0019	CcSEcCtD
Propofol—Tachycardia—Docetaxel—melanoma	0.000143	0.0019	CcSEcCtD
Propofol—Headache—Carmustine—melanoma	0.000143	0.00189	CcSEcCtD
Propofol—Vomiting—Temozolomide—melanoma	0.00014	0.00186	CcSEcCtD
Propofol—Rash—Temozolomide—melanoma	0.000139	0.00184	CcSEcCtD
Propofol—Dermatitis—Temozolomide—melanoma	0.000139	0.00184	CcSEcCtD
Propofol—Headache—Temozolomide—melanoma	0.000138	0.00183	CcSEcCtD
Propofol—Hypotension—Docetaxel—melanoma	0.000137	0.00182	CcSEcCtD
Propofol—Nausea—Carmustine—melanoma	0.000135	0.0018	CcSEcCtD
Propofol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000133	0.00177	CcSEcCtD
Propofol—Insomnia—Docetaxel—melanoma	0.000132	0.00176	CcSEcCtD
Propofol—Paraesthesia—Docetaxel—melanoma	0.000131	0.00174	CcSEcCtD
Propofol—Nausea—Temozolomide—melanoma	0.000131	0.00174	CcSEcCtD
Propofol—Dyspnoea—Docetaxel—melanoma	0.00013	0.00173	CcSEcCtD
Propofol—Somnolence—Docetaxel—melanoma	0.00013	0.00173	CcSEcCtD
Propofol—Fatigue—Docetaxel—melanoma	0.000126	0.00167	CcSEcCtD
Propofol—Pain—Docetaxel—melanoma	0.000125	0.00166	CcSEcCtD
Propofol—Feeling abnormal—Docetaxel—melanoma	0.000121	0.0016	CcSEcCtD
Propofol—Abdominal pain—Docetaxel—melanoma	0.000116	0.00154	CcSEcCtD
Propofol—Body temperature increased—Docetaxel—melanoma	0.000116	0.00154	CcSEcCtD
Propofol—Asthenia—Docetaxel—melanoma	0.000105	0.00139	CcSEcCtD
Propofol—Pruritus—Docetaxel—melanoma	0.000104	0.00137	CcSEcCtD
Propofol—Diarrhoea—Docetaxel—melanoma	0.0001	0.00133	CcSEcCtD
Propofol—Dizziness—Docetaxel—melanoma	9.68e-05	0.00128	CcSEcCtD
Propofol—Vomiting—Docetaxel—melanoma	9.3e-05	0.00124	CcSEcCtD
Propofol—Rash—Docetaxel—melanoma	9.23e-05	0.00122	CcSEcCtD
Propofol—Dermatitis—Docetaxel—melanoma	9.22e-05	0.00122	CcSEcCtD
Propofol—Headache—Docetaxel—melanoma	9.17e-05	0.00122	CcSEcCtD
Propofol—Nausea—Docetaxel—melanoma	8.69e-05	0.00115	CcSEcCtD
Propofol—CYP2C18—Metabolism—PTGS2—melanoma	5.55e-06	5.08e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC5A5—melanoma	5.54e-06	5.07e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—HPSE—melanoma	5.53e-06	5.06e-05	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	5.53e-06	5.06e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC5A5—melanoma	5.51e-06	5.04e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP17A1—melanoma	5.44e-06	4.98e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CUBN—melanoma	5.43e-06	4.97e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—melanoma	5.39e-06	4.94e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.37e-06	4.92e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.36e-06	4.91e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CD44—melanoma	5.35e-06	4.9e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GNAQ—melanoma	5.35e-06	4.9e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CD44—melanoma	5.32e-06	4.87e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GNAQ—melanoma	5.32e-06	4.87e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	5.29e-06	4.85e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—melanoma	5.25e-06	4.81e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SDHD—melanoma	5.24e-06	4.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CSPG4—melanoma	5.24e-06	4.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—BSG—melanoma	5.24e-06	4.8e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.24e-06	4.79e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.21e-06	4.77e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—melanoma	5.2e-06	4.76e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.19e-06	4.75e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.16e-06	4.72e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GNA11—melanoma	5.14e-06	4.7e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1B1—melanoma	5.13e-06	4.69e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1B1—melanoma	5.1e-06	4.67e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CD—melanoma	5.08e-06	4.65e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CD—melanoma	5.08e-06	4.65e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GPAM—melanoma	5.07e-06	4.65e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—FASN—melanoma	5.03e-06	4.6e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—VCAN—melanoma	5.02e-06	4.6e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ALB—melanoma	5.02e-06	4.59e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ALB—melanoma	5.02e-06	4.59e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP17A1—melanoma	5e-06	4.58e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ABCB1—melanoma	4.99e-06	4.57e-05	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—melanoma	4.97e-06	4.55e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP17A1—melanoma	4.96e-06	4.54e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC5A5—melanoma	4.94e-06	4.53e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.94e-06	4.52e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.89e-06	4.48e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ABCB1—melanoma	4.89e-06	4.47e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—melanoma	4.84e-06	4.43e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.83e-06	4.42e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GNAQ—melanoma	4.77e-06	4.37e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CD44—melanoma	4.77e-06	4.37e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.75e-06	4.35e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CD—melanoma	4.74e-06	4.34e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GNA11—melanoma	4.72e-06	4.32e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GNA11—melanoma	4.68e-06	4.29e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ALB—melanoma	4.68e-06	4.28e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.67e-06	4.28e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.63e-06	4.24e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—FASN—melanoma	4.62e-06	4.23e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ABCB1—melanoma	4.61e-06	4.22e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PRKCA—melanoma	4.59e-06	4.2e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.59e-06	4.2e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—FASN—melanoma	4.58e-06	4.2e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1B1—melanoma	4.58e-06	4.19e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ERCC2—melanoma	4.55e-06	4.17e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC5A5—melanoma	4.55e-06	4.16e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.53e-06	4.14e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC5A5—melanoma	4.51e-06	4.13e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.5e-06	4.12e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PRKCA—melanoma	4.5e-06	4.12e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—melanoma	4.46e-06	4.09e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ERCC2—melanoma	4.46e-06	4.08e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—melanoma	4.46e-06	4.08e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CB—melanoma	4.43e-06	4.06e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CB—melanoma	4.43e-06	4.06e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—melanoma	4.41e-06	4.04e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GNAQ—melanoma	4.39e-06	4.02e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CD44—melanoma	4.39e-06	4.02e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—melanoma	4.39e-06	4.02e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—melanoma	4.39e-06	4.02e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GNAQ—melanoma	4.35e-06	3.99e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CD44—melanoma	4.35e-06	3.99e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PLA2G6—melanoma	4.31e-06	3.95e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—melanoma	4.3e-06	3.94e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.26e-06	3.9e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PRKCA—melanoma	4.24e-06	3.88e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP17A1—melanoma	4.24e-06	3.88e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.22e-06	3.87e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK3—melanoma	4.22e-06	3.87e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ABCB1—melanoma	4.22e-06	3.87e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1B1—melanoma	4.21e-06	3.85e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ERCC2—melanoma	4.2e-06	3.85e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—ABCB1—melanoma	4.2e-06	3.84e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.18e-06	3.83e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1B1—melanoma	4.17e-06	3.82e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CB—melanoma	4.13e-06	3.78e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.13e-06	3.78e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—melanoma	4.09e-06	3.75e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.04e-06	3.7e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK1—melanoma	4.02e-06	3.68e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GNA11—melanoma	4e-06	3.66e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CD—melanoma	3.92e-06	3.59e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—FASN—melanoma	3.92e-06	3.58e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PRKCA—melanoma	3.89e-06	3.56e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—VCAN—melanoma	3.88e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ALB—melanoma	3.87e-06	3.54e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PRKCA—melanoma	3.86e-06	3.54e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ERCC2—melanoma	3.85e-06	3.53e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A5—melanoma	3.85e-06	3.53e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—ERCC2—melanoma	3.83e-06	3.51e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—melanoma	3.83e-06	3.5e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—melanoma	3.83e-06	3.5e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—melanoma	3.8e-06	3.47e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ABCB1—melanoma	3.77e-06	3.45e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GNAQ—melanoma	3.72e-06	3.41e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CD44—melanoma	3.72e-06	3.41e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.68e-06	3.37e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.64e-06	3.33e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.61e-06	3.3e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—melanoma	3.6e-06	3.29e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—melanoma	3.57e-06	3.27e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP1B1—melanoma	3.57e-06	3.27e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—melanoma	3.52e-06	3.22e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—melanoma	3.49e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.48e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—melanoma	3.47e-06	3.18e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PRKCA—melanoma	3.47e-06	3.18e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ABCB1—melanoma	3.47e-06	3.17e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ERCC2—melanoma	3.44e-06	3.15e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ABCB1—melanoma	3.44e-06	3.15e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—melanoma	3.42e-06	3.13e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CB—melanoma	3.41e-06	3.13e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—melanoma	3.4e-06	3.11e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—melanoma	3.38e-06	3.1e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—melanoma	3.37e-06	3.09e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—melanoma	3.32e-06	3.04e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP17A1—melanoma	3.27e-06	2.99e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—melanoma	3.23e-06	2.95e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—melanoma	3.2e-06	2.93e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.19e-06	2.92e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PRKCA—melanoma	3.19e-06	2.92e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.17e-06	2.91e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ERCC2—melanoma	3.16e-06	2.9e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PRKCA—melanoma	3.16e-06	2.9e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CD—melanoma	3.16e-06	2.89e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.15e-06	2.88e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ERCC2—melanoma	3.14e-06	2.87e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ALB—melanoma	3.12e-06	2.86e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CD—melanoma	3.1e-06	2.83e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GNA11—melanoma	3.09e-06	2.83e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ALB—melanoma	3.06e-06	2.8e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—melanoma	3.04e-06	2.79e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—melanoma	3.03e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—FASN—melanoma	3.02e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A5—melanoma	2.97e-06	2.72e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—melanoma	2.95e-06	2.7e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—melanoma	2.94e-06	2.69e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ABCB1—melanoma	2.94e-06	2.69e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—melanoma	2.92e-06	2.67e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CD—melanoma	2.92e-06	2.67e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ALB—melanoma	2.88e-06	2.64e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GNAQ—melanoma	2.87e-06	2.63e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CD44—melanoma	2.87e-06	2.63e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.85e-06	2.61e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—melanoma	2.85e-06	2.61e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—melanoma	2.79e-06	2.55e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CB—melanoma	2.76e-06	2.52e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1B1—melanoma	2.75e-06	2.52e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—melanoma	2.73e-06	2.5e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—melanoma	2.72e-06	2.49e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PRKCA—melanoma	2.7e-06	2.47e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—melanoma	2.7e-06	2.47e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—melanoma	2.7e-06	2.47e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CB—melanoma	2.7e-06	2.47e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ERCC2—melanoma	2.68e-06	2.45e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CD—melanoma	2.68e-06	2.45e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—melanoma	2.67e-06	2.45e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CD—melanoma	2.66e-06	2.44e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ALB—melanoma	2.64e-06	2.42e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—melanoma	2.62e-06	2.4e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.6e-06	2.38e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CB—melanoma	2.54e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—melanoma	2.52e-06	2.31e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—melanoma	2.52e-06	2.31e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—melanoma	2.5e-06	2.29e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—melanoma	2.48e-06	2.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—melanoma	2.41e-06	2.21e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—melanoma	2.39e-06	2.19e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CD—melanoma	2.39e-06	2.19e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—melanoma	2.38e-06	2.18e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ALB—melanoma	2.36e-06	2.16e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CB—melanoma	2.33e-06	2.14e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—melanoma	2.33e-06	2.13e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CB—melanoma	2.32e-06	2.12e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—melanoma	2.31e-06	2.12e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—melanoma	2.3e-06	2.1e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ABCB1—melanoma	2.27e-06	2.08e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.22e-06	2.03e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—melanoma	2.21e-06	2.02e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—melanoma	2.21e-06	2.02e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—melanoma	2.2e-06	2.01e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CD—melanoma	2.2e-06	2.01e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CD—melanoma	2.18e-06	1.99e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ALB—melanoma	2.17e-06	1.99e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ALB—melanoma	2.15e-06	1.97e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—melanoma	2.12e-06	1.94e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PRKCA—melanoma	2.09e-06	1.91e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CB—melanoma	2.08e-06	1.91e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—melanoma	2.08e-06	1.91e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ERCC2—melanoma	2.07e-06	1.89e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—melanoma	2.06e-06	1.89e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—melanoma	2.06e-06	1.88e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—melanoma	2.04e-06	1.87e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—melanoma	2.02e-06	1.85e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—melanoma	2e-06	1.83e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CB—melanoma	1.91e-06	1.75e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CB—melanoma	1.9e-06	1.74e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—melanoma	1.9e-06	1.74e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—melanoma	1.88e-06	1.72e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CD—melanoma	1.86e-06	1.7e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ALB—melanoma	1.84e-06	1.68e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—melanoma	1.8e-06	1.65e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—melanoma	1.7e-06	1.56e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—melanoma	1.68e-06	1.54e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—melanoma	1.65e-06	1.51e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—melanoma	1.65e-06	1.51e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—melanoma	1.64e-06	1.5e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—melanoma	1.63e-06	1.5e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CB—melanoma	1.62e-06	1.49e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—melanoma	1.61e-06	1.47e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—melanoma	1.58e-06	1.44e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—melanoma	1.55e-06	1.42e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CD—melanoma	1.44e-06	1.31e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—melanoma	1.42e-06	1.3e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALB—melanoma	1.42e-06	1.3e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—melanoma	1.41e-06	1.29e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—melanoma	1.4e-06	1.28e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—melanoma	1.37e-06	1.26e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—melanoma	1.34e-06	1.23e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—melanoma	1.27e-06	1.16e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—melanoma	1.27e-06	1.16e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CB—melanoma	1.25e-06	1.15e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—melanoma	1.24e-06	1.14e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—melanoma	1.17e-06	1.07e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—melanoma	1.16e-06	1.06e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—melanoma	1.16e-06	1.06e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—melanoma	1.15e-06	1.06e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—melanoma	1.08e-06	9.9e-06	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—melanoma	1.04e-06	9.49e-06	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—melanoma	9.89e-07	9.05e-06	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—melanoma	9.54e-07	8.73e-06	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—melanoma	9.45e-07	8.65e-06	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—melanoma	8.08e-07	7.4e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—melanoma	7.63e-07	6.99e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—melanoma	6.23e-07	5.71e-06	CbGpPWpGaD
